Keyphrases
Phase II Study
100%
Irradiation
100%
Concurrent Chemotherapy
100%
Radical Hysterectomy
100%
Invasive Cervical Cancer
100%
Hysterectomy
40%
5-fluorouracil (5-FU)
40%
Initial Treatment
20%
Overall Survival
20%
Long-term Survival
20%
Chemotherapy
20%
Logistic Regression
20%
Pelvis
20%
Cervical Cancer
20%
Treatment Regimen
20%
Follow-up Time
20%
Radiation Dose
20%
Long-term Complications
20%
Concurrent Cisplatin
20%
Fistula
20%
Acute Toxicity
20%
Pelvic Recurrence
20%
Cisplatin
20%
Late Toxicity
20%
Long-term Efficacy
20%
Treatment Complications
20%
Long-term Toxicity
20%
Rectovaginal Fistula
20%
Pelvic Irradiation
20%
Metastatic Cervical Cancer
20%
Pelvic Abscess
20%
Leg Edema
20%
Vesicovaginal
20%
Medicine and Dentistry
Cervical Cancer
100%
Radical Hysterectomy
100%
Chemotherapy
100%
Hysterectomy
50%
Pelvis
50%
Cisplatin
50%
Overall Survival
25%
Long Term Survival
25%
Logistic Regression Analysis
25%
Recurrent Disease
25%
Fistula
25%
Acute Toxicity
25%
Rectovaginal Fistula
25%
Pelvic Radiotherapy
25%
Pelvis Abscess
25%
Leg Edema
25%
Nursing and Health Professions
Uterine Cervix Cancer
100%
Radical Hysterectomy
100%
Cisplatin
50%
Hysterectomy
50%
Overall Survival
25%
Logistic Regression Analysis
25%
Long Term Survival
25%
Recurrent Disease
25%
Fistula
25%
Pelvis Abscess
25%
Acute Toxicity
25%
Leg Edema
25%
Rectovaginal Fistula
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Uterine Cervix Cancer
100%
Cisplatin
50%
Overall Survival
25%
Recurrent Disease
25%
Long Term Survival
25%
Acute Toxicity
25%
Fistula
25%
Rectovaginal Fistula
25%
Leg Edema
25%
Pelvis Abscess
25%
Biochemistry, Genetics and Molecular Biology
Cisplatin
100%
Overall Survival
50%
Long Term Survival
50%